Rapport Therapeutics, Inc. RAPP 深 沪
等待开盘 05-11 09:30:00 美东时间
38.04
-1.890
-4.73%
华盛通- 最 高40.80
- 今 开39.97
- 成交量 37.19万股
- 最 低 34.75
- 昨 收 39.93
- 总市值 0
- 52周最高 42.2685
- 市盈率 静 --
- 换手率 Infinity.00%
- 52周最低 7.73
- 委 比 28.43%
- 总股本 --
- 历史最高 42.2685
- 量 比 0.79
- 振 幅 15.15%
- 历史最低 6.43
- 每 手 1
- 风险率 7.89%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Xenon Pharmaceuticals Rallies After Pivotal Data Shows Major Drop In Monthly Seizures
Xenon Pharmaceuticals shares surge after Phase 3 data show strong seizure reduction for azetukalner, with FDA filing planned for 2026.
03-09 21:26
生物制药公司Rapport重挫18.8%，此前完成2.5亿美元的公开发行
美股周三早盘，专注于中枢神经系统（CNS）疾病创新疗法研发的生物制药公司Rapport Therapeutics（RAPP）股价重挫18.8%，此前该公司以每股26美元的价格完成2.5亿美元的公开发行。 此次发行预计将于2025年9月11日完成，所筹资金将用于支持公司的增长计划。 海量资讯、精准解读，尽在新浪财经APP 责任编辑：张俊 SF065
2025-09-10 22:54
Rapport Therapeutics Hosts Investor and Analyst Day; Provides Corporate Updates
The Phase 2a trial of Rapport Therapeutics' RAP-219 for refractory focal epilepsy is fully enrolled, with topline results expected in September 2025. The company highlighted the drug's potential in epilepsy, bipolar mania, and neuropathic pain during its investor day and has sufficient funds through 2026.
2025-06-02 18:45
Rapport Therapeutics to Participate in the Jefferies Global Healthcare Conference and Goldman Sachs 46th Annual Global Healthcare Conference
Rapport Therapeutics announced that its management will participate in two upcoming investor conferences: the Jefferies Global Healthcare Conference in New York City on June 4 and the Goldman Sachs Global Healthcare Conference in Miami on June 9.
2025-05-27 11:00
Why Gap Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Shares of The Gap, Inc. (NYSE:GAP) rose sharply in today's pre-market trading a...
2025-03-07 20:19
